Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tim Waterboer

Showing results (141-150 of 431) with videos related to

Pageof 44
Sort By:
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 25, 2019
Mucosal and cutaneous Human Papillomavirus seroprevalence among adults in the prevaccine era in Germany - Results from a nationwide population-based surveyAnna D Loenenbach, Christina Poethko-Müller, Michael Pawlita, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 5, 2020
Humoral Response to HPV16 Proteins in Persons with Anal High-Grade Squamous Intraepithelial Lesion or Anal CancerHelen C Stankiewicz Karita, Tim Waterboer, Amalia Magaret, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 20, 2017
Prediagnostic Antibodies to Serum p53 and Subsequent Colorectal CancerLauren R Teras, Susan M Gapstur, Maret L Maliniak, et al.
Cancer Epidemiology|November 4, 2022
Pre-diagnostic circulating p53 autoantibodies and subsequent lung cancer risk in low-income African and European AmericansHyung-Suk Yoon, Wei Zheng, Hui Cai, et al.
Frontiers in Public Health|May 10, 2019
<i>Helicobacter pylori</i> Seropositivity: Prevalence, Associations, and the Impact on Incident Metabolic Diseases/Risk Factors in the Population-Based KORA StudyNina Wawro, Ute Amann, Julia Butt, et al.
Microbiology Spectrum|April 30, 2024
Empirical sample-specific approaches to define HPV16 and HPV18 seropositivity in unvaccinated, young, sexually active womenKristy Ng, Samantha Morais, Michel D Wissing, et al.
Infectious Agents and Cancer|September 16, 2009
The sero-epidemiology of human papillomavirus among Caucasian transplant recipients in the UKDelphine Casabonne, Tim Waterboer, Kristina M Michael, et al.
International Journal of Cancer|April 13, 2020
Epstein-Barr virus and human papillomavirus serum antibodies define the viral status of nasopharyngeal carcinoma in a low endemic countryJulia Simon, Lea Schroeder, Kate Ingarfield, et al.
Annals of Neurology|June 11, 2024
Interactions between High Seroreactivity to Human Herpes Virus 6A and Epstein-Barr Virus in MS Development: A Presymptomatic Case-Control StudyViktor Grut, Martin Biström, Jonatan Salzer, et al.
Open Forum Infectious Diseases|April 14, 2026
Protective Human Papillomavirus Type 16/18 Vaccine-Induced Neutralizing Antibody Levels Remain ElusiveMatti Lehtinen, Tiina Eriksson, Tiina Petäjä, et al.
Pageof 44

Showing results (141-150 of 431) with videos related to

Sort By:
Pageof 44
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 25, 2019
Mucosal and cutaneous Human Papillomavirus seroprevalence among adults in the prevaccine era in Germany - Results from a nationwide population-based surveyAnna D Loenenbach, Christina Poethko-Müller, Michael Pawlita, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 5, 2020
Humoral Response to HPV16 Proteins in Persons with Anal High-Grade Squamous Intraepithelial Lesion or Anal CancerHelen C Stankiewicz Karita, Tim Waterboer, Amalia Magaret, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 20, 2017
Prediagnostic Antibodies to Serum p53 and Subsequent Colorectal CancerLauren R Teras, Susan M Gapstur, Maret L Maliniak, et al.
Cancer Epidemiology|November 4, 2022
Pre-diagnostic circulating p53 autoantibodies and subsequent lung cancer risk in low-income African and European AmericansHyung-Suk Yoon, Wei Zheng, Hui Cai, et al.
Frontiers in Public Health|May 10, 2019
<i>Helicobacter pylori</i> Seropositivity: Prevalence, Associations, and the Impact on Incident Metabolic Diseases/Risk Factors in the Population-Based KORA StudyNina Wawro, Ute Amann, Julia Butt, et al.
Microbiology Spectrum|April 30, 2024
Empirical sample-specific approaches to define HPV16 and HPV18 seropositivity in unvaccinated, young, sexually active womenKristy Ng, Samantha Morais, Michel D Wissing, et al.
Infectious Agents and Cancer|September 16, 2009
The sero-epidemiology of human papillomavirus among Caucasian transplant recipients in the UKDelphine Casabonne, Tim Waterboer, Kristina M Michael, et al.
International Journal of Cancer|April 13, 2020
Epstein-Barr virus and human papillomavirus serum antibodies define the viral status of nasopharyngeal carcinoma in a low endemic countryJulia Simon, Lea Schroeder, Kate Ingarfield, et al.
Annals of Neurology|June 11, 2024
Interactions between High Seroreactivity to Human Herpes Virus 6A and Epstein-Barr Virus in MS Development: A Presymptomatic Case-Control StudyViktor Grut, Martin Biström, Jonatan Salzer, et al.
Open Forum Infectious Diseases|April 14, 2026
Protective Human Papillomavirus Type 16/18 Vaccine-Induced Neutralizing Antibody Levels Remain ElusiveMatti Lehtinen, Tiina Eriksson, Tiina Petäjä, et al.
Pageof 44